Ignite Creation Date:
2024-05-05 @ 5:36 PM
Last Modification Date:
2024-10-26 @ 9:33 AM
Study NCT ID:
NCT00487513
Status:
COMPLETED
Last Update Posted:
2017-03-09
First Post:
2007-06-15
Brief Title:
Procurement of Follicular B Cell Lymphoma Cells for the Purpose of Possible Use in Future Clinical Trials
Sponsor:
Dana-Farber Cancer Institute
Organization:
Dana-Farber Cancer Institute
Study Overview
Official Title:
Procurement of Follicular B Cell Lymphoma Cells From Blood Tissue or Malignant Effusion for the Purpose of Possible Use in Future Clinical Trials A Minimal Risk Protocol
Status:
COMPLETED
Status Verified Date:
2017-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
In order to learn more about follicular lymphoma and anti-cancer vaccines we are collecting samples from people with this diagnosis We then hope to make a vaccine from this tissue to help the immune system destroy cancer cells We plan on keeping samples in the tissue bank indefinitely
Detailed Description:
- The following tests and procedures will be performed Approximately 50cc of peripheral blood will be drawn and stored in the tissue bank patients who have follicular lymphoma cells circulating in the blood will have about 40ccs of blood drawn and stored for processing patients undergoing a lymph node biopsy will have samples of the biopsy stored patients having fluid drained from the abdomen or from around the lung will have some of their fluid saved to cell collection and processing patients undergoing a bone marrow biopsy will have some of the sample stored for cell collection and processing
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None